60 Degrees Pharmaceuticals, Inc. (SXTP) Ratios

242 Followers

60 Degrees Pharmaceuticals, Inc. Ratios

SXTP's free cash flow for Q4 2025 was $0.60. For the 2025 fiscal year, SXTP's free cash flow was decreased by $ and operating cash flow was $-4.74. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	―	2.66	3.25	2.55	0.05
Quick Ratio	―	2.30	2.98	2.39	0.02
Cash Ratio	―	0.82	1.00	0.76	0.01
Solvency Ratio	―	-3.67	-4.37	-1.23	-0.24
Operating Cash Flow Ratio	―	-3.72	-3.41	-1.60	-0.04
Short-Term Operating Cash Flow Coverage	―	-780.78	-643.88	-517.89	-0.05
Net Current Asset Value	$ ―	$ 2.91M	$ 3.58M	$ 4.26M	$ -24.35M
Leverage Ratios
Debt-to-Assets Ratio	―	0.03	0.03	0.02	17.28
Debt-to-Equity Ratio	―	0.04	0.04	0.04	-0.95
Debt-to-Capital Ratio	―	0.04	0.04	0.03	-19.35
Long-Term Debt-to-Capital Ratio	―	0.04	0.04	0.03	-0.06
Financial Leverage Ratio	―	1.55	1.43	1.60	-0.06
Debt Service Coverage Ratio	―	-439.02	-472.55	-0.62	-0.08
Interest Coverage Ratio	―	-994.05	-1.23K	-2.25	-0.44
Debt to Market Cap	―	0.11	0.05	<0.01	0.01
Interest Debt Per Share	―	0.24	1.44	2.48	18.27
Net Debt to EBITDA	―	0.19	0.19	1.38	-10.50
Profitability Margins
Gross Profit Margin	―	22.26%	36.67%	-87.15%	-93.71%
EBIT Margin	―	-732.05%	-1308.07%	-602.16%	-980.22%
EBITDA Margin	―	-723.80%	-1297.58%	-562.58%	-944.92%
Operating Profit Margin	―	-771.64%	-1598.97%	-2032.78%	-784.22%
Pretax Profit Margin	―	-732.82%	-1309.37%	-1503.93%	-2767.50%
Net Profit Margin	―	-732.82%	-1308.01%	-1485.06%	-2769.49%
Continuous Operations Profit Margin	―	-732.82%	-1309.41%	-1504.02%	-2767.73%
Net Income Per EBT	―	100.00%	99.90%	98.75%	100.07%
EBT Per EBIT	―	94.97%	81.89%	73.98%	352.90%
Return on Assets (ROA)	―	-137.31%	-137.99%	-48.38%	-476.54%
Return on Equity (ROE)	―	-212.76%	-196.93%	-77.32%	26.22%
Return on Capital Employed (ROCE)	―	-220.20%	-236.83%	-104.17%	7.74%
Return on Invested Capital (ROIC)	―	-219.65%	-236.32%	-103.70%	118.61%
Return on Tangible Assets	―	-143.30%	-141.86%	-49.83%	-545.63%
Earnings Yield	―	-541.58%	-271.04%	-1.55%	-0.38%
Efficiency Ratios
Receivables Turnover	―	1.97	1.25	1.10	4.86
Payables Turnover	―	0.54	0.38	0.94	0.57
Inventory Turnover	―	1.19	0.87	1.02	0.83
Fixed Asset Turnover	―	4.08	4.06	3.56	6.58
Asset Turnover	―	0.19	0.11	0.03	0.17
Working Capital Turnover Ratio	―	0.30	0.15	-0.03	-0.02
Cash Conversion Cycle	―	-189.64	-243.42	302.19	-127.52
Days of Sales Outstanding	―	185.01	292.41	332.99	75.16
Days of Inventory Outstanding	―	306.74	420.02	358.55	437.78
Days of Payables Outstanding	―	681.39	955.86	389.35	640.46
Operating Cycle	―	491.75	712.43	691.54	512.94
Cash Flow Ratios
Operating Cash Flow Per Share	―	-10.22	-49.70	-4.59	-0.70
Free Cash Flow Per Share	―	-10.54	-51.29	-4.71	-0.74
CapEx Per Share	―	0.33	1.59	0.12	0.04
Free Cash Flow to Operating Cash Flow	―	1.03	1.03	1.03	1.06
Dividend Paid and CapEx Coverage Ratio	―	-31.41	-31.19	-39.20	-16.80
Capital Expenditure Coverage Ratio	―	-31.41	-31.19	-39.20	-16.80
Operating Cash Flow Coverage Ratio	―	-44.83	-36.23	-26.31	-0.05
Operating Cash Flow to Sales Ratio	―	-6.81	-9.30	-17.92	-4.52
Free Cash Flow Yield	―	-519.44%	-198.81%	-1.92%	-0.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-0.18	-0.37	-64.36	-262.63
Price-to-Sales (P/S) Ratio	―	1.35	4.83	955.82	7.27K
Price-to-Book (P/B) Ratio	―	0.39	0.73	49.77	-68.86
Price-to-Free Cash Flow (P/FCF) Ratio	―	-0.19	-0.50	-52.02	-1.52K
Price-to-Operating Cash Flow Ratio	―	-0.20	-0.52	-53.35	-1.61K
Price-to-Earnings Growth (PEG) Ratio	―	<0.01	>-0.01	5.74	-5.89
Price-to-Fair Value	―	0.39	0.73	49.77	-68.86
Enterprise Value Multiple	―	>-0.01	-0.18	-168.52	-780.26
Enterprise Value	―	3.24K	1.43M	240.40M	1.65B
EV to EBITDA	―	>-0.01	-0.18	-168.52	-780.26
EV to Sales	―	<0.01	2.35	948.05	7.37K
EV to Free Cash Flow	―	>-0.01	-0.25	-51.60	-1.54K
EV to Operating Cash Flow	―	>-0.01	-0.25	-52.92	-1.63K
Tangible Book Value Per Share	―	4.71	33.42	4.62	-16.82
Shareholders’ Equity Per Share	―	5.17	35.51	4.92	-16.31
Tax and Other Ratios
Effective Tax Rate	―	0.00	>-0.01	>-0.01	>-0.01
Revenue Per Share	―	1.50	5.35	0.26	0.15
Net Income Per Share	―	-10.99	-69.93	-3.80	-4.28
Tax Burden	―	1.00	1.00	0.99	1.00
Interest Burden	―	1.00	1.00	2.50	2.82
Research & Development to Revenue	―	2.09	8.21	2.73	2.35
SG&A to Revenue	―	6.25	8.27	16.73	5.84
Stock-Based Compensation to Revenue	―	0.00	5.94	0.00	0.00
Income Quality	―	0.00	0.71	1.21	0.16

Currency in USD